|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Kleinstäuber, M.; Allwang, C.; Bailer, J.; Berking, M.; Brünahl, C.; Erkic, M.; Gitzen, H.; Gollwitzer, Mario 
ORCID: https://orcid.org/0000-0003-4310-4793; Gottschalk, J.-M.; Heider, J.; Hermann, A.; Lahmann, C.; Löwe, B.; Martin, A.; Rau, J.; Schröder, A.; Schwabe, Johannes; Schwarz, J.; Stark, R.; Weiss, F. D. und Rief, W.
(September 2019):
Cognitive Behaviour Therapy Complemented with Emotion Regulation Training for Patients with Persistent Physical Symptoms. A Randomised Clinical Trial.
In: Psychotherapy and Psychosomatics, Bd. 88, Nr. 5: S. 287-299
ORCID: https://orcid.org/0000-0003-4310-4793; Gottschalk, J.-M.; Heider, J.; Hermann, A.; Lahmann, C.; Löwe, B.; Martin, A.; Rau, J.; Schröder, A.; Schwabe, Johannes; Schwarz, J.; Stark, R.; Weiss, F. D. und Rief, W.
(September 2019):
Cognitive Behaviour Therapy Complemented with Emotion Regulation Training for Patients with Persistent Physical Symptoms. A Randomised Clinical Trial.
In: Psychotherapy and Psychosomatics, Bd. 88, Nr. 5: S. 287-299
Knudsen, K.; Krack, P.; Tonder, L.; Houeto, J. -L.; Rau, J.; Schade-Brittinger, C.; Hartmann, A.; Haelbig, Thomas D.; Paschen, Stephen; Barbe, Michael T.; Kühn, Andrea; Fraix, Valerie; Brefel-Courbon, Christine; Vesper, Jan; Maltete, David; Sixel-Döring, Friederike; Weiss, Daniel; Witjas, Tatiana; Thobois, Stephane; Agid, Yves; Schnitzler, A.; Schuepbach, W. M. M.; Timmermann, L.; Damier, Philippe; Vidailhet, M.; Deuschl, G.; Czernecki, Virginie; Hesekamp, Helke; Meier, Nildaus; Negovanska, Velina; Welter, Marie-Laure; Corvol, Jean-Christophe; Pineau, Fanny; Cornu, Philippe; Navarro, Soledad; Paschen, Laura; Paschen, Stephen; Volkmann, Jens; Moeller, Bettina; Nebel, Adelheid; Witt, Karsten; Raethjen, Jan; Falk, Daniels; Mehdorn, Maktnilian; Meister, Ingo G.; Kuhn, Jens; Dafsari, Haidar S.; Fink, Gereon R.; Donner, Kerstin; Kessler, Josef; Maarouf, Mohammad; Kupsch, Andeas; Schneider, Gerd -H.; Gruber, Doreen; Müller, Bianca; Faust, Katharina; Chabardes, Stephan; Kistler, Andrea; Pollak, Pierre; Ory-Magne, Fabienne; Rascol, Oliver; Arbus, Christophe; Chaynes, P. Patrick; Danet, Lola; Derrey, Stephane; Lefaucheur, Romain; Benatru, Isabelle; Bataille, Benoit; Colin, Olivier; Wojtecki, Lars; Groiss, Stefan J.; Elben, Saskia; Hartmann, Christian; Suedmeyer, Martin; Pinsker, Marcus O.; Amtage, Florian; Gharabaghi, Alireza; Waechter, Tobias; Krüger, Rejko; Derkinderen, Pascal; Ledily, Severine; Raoul, Sylvia; Sauvaget, Anne; Elena-Klinik, Paracelsus; Trenkwalder, Claudia; Richter-Dreske, Wenke; Regis, Jean-Marie; Eusebio, Alexandro; Philippe, Jean; Polo, Gustavo; Pinto, Serge; Mertens, Patrick; Levin, Johannes; Oertel, Wolfgang H.; Dornier, Stephanie; Pene, Fredy; Hourton, Delphine; Bissery, Anne; Bouton, Didier; Quintin, Mathieu; Hoffart-Jourdain, Cecile; Brocvielle, Helene; Partowinia-Peters, Mahnaz; Schickor, Mandy; Balthasar, Kerstin; Stein, Meryem; Harnisch, Susanne; Reuss, Alexander; Aminossadati, Behnaz; Nasemann, Christian und Stoker, Valerie
(2019):
Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.
In: Parkinsonism & Related Disorders, Bd. 65: S. 217-223
Mahner, S.; Lueck, H.-J.; Grischke, E.-M.; Rau, J.; Gropp-Meier, M.; Schmalfeldt, B.; Meier, W.; Hasenburg, A.; Belau, A.; Vergote, I.; Zorr, A.; Huels, R.; Gerber, B.; Bois, A. du; Marme, F.; Hilpert, F.; Canzler, U. und Kurzeder, C.
(2016):
Chemotherapy (CT) +/- pertuzumab (P) for platinum-resistant ovarian cancer (PROC): AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomized phase 3 trial.
In: Oncology Research and Treatment, Bd. 39: S. 97
Hilbert, F.; Gropp-Meier, M.; Schmalfeldt, B.; Rau, J.; Meier, W.; Hasenburg, A.; Belau, A.; Vergote, I.; Zorr, A.; Hils, R.; Gerber, B.; Bois, A. du; Marme, F.; Mahner, S.; Canzler, U.; Lück, H.-J.; Grischke, E.-M. und Kurzeder, C.
(2016):
Patient-reported outcome (PRO) results from the AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebo-controlled randomised phase III trial evaluating chemotherapy +/- pertuzumab for platinum-resistant ovarian cancer (PROC).
In: Oncology Research and Treatment, Bd. 39: S. 138